PDX
Navigation Links
PDX in Medical News
Emdeon Acquires eRx Network, LLC
...ition, Emdeon, PDX, Inc. and eRx entered into a long term extension and expansion of the strategic relationship that has been in place between eRx and pdx since eRx's founding. "We are delighted to combine our pharmacy business with eRx," said George Lazenby, chief executive officer of Emdeon. "Th...PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients
...TM) FORT WORTH, Texas, June 9 /PRNewswire/ -- pdx and Rx.com have entered into a strategic agreement...ients' prescription history into HealthVault. Each pdx pharmacy client will have their own independent relationship with Microsoft, while pdx serves to technically integrate the pharmacy's dat...Albertson's, LLC Selects PDX-NHIN-Rx.com to Provide Complete Pharmacy Management Solution
...- Boise, Idaho-based Albertson's, LLC has selected pdx and affiliates Rx.com and NHIN as its turnkey part...ess was pharmacy software development. In the end, pdx best met our needs." George Owens, Senior Vice President at pdx said, "We are especially pleased to have Albertson...New lymphoma therapies targets diverse and difficult cancer
...ne at Columbia University College of Physicians and Surgeons. One of the most promising new therapies developed at NewYork-Presbyterian/Columbia is pdx (pralatrexate) for T-cell lymphoma -- among the most fatal forms of the disease. The drug is uniquely designed to camouflage itself as a folic acid, w...Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeut...Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference
... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeut...PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File
...ave entered into an agreement to jointly market to pdx Pharmacy System users the HMS Prescriber Master Fi... provided through NHIN in a manner that will allow pdx customers to access this data using PDX Distributed Processing, a feature of the pdx Pharmacy System that allows access to databases in...Allos Therapeutics Reports Third Quarter 2007 Financial Results
...September 30, 2007 were $63.4 million. "With five pdx trials ongoing and two additional studies schedule...ke important progress advancing the development of pdx in hematologic malignancies and solid tumors," sta...er of Allos. "PROPEL, our pivotal Phase 2 trial of pdx in patients with relapsed or refractory peripheral...Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference
... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of other lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemothe...HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...et, Inc. HNT 311854162.6 Davita Inc DVA 230769230.8 Pediatrix Medical Group pdx 173618639.9 Humana Inc. HUM 138944124.3 Healthsouth Corp HLS 525336900.2 Che...PDX in Medical Technology
WESTMINSTER, Colo., Dec. 27 /PRNewswire-FirstCall/ -- Allos
Therapeutics, Inc. (Nasdaq: ALTH ) today announced that an independent Data
Monitoring Committee (DMC) has completed the pre-specified 65-patient
safety review of data from the Company's pivotal Phase 2 PROPEL trial of
PDX (pralatrex...
PROPEL Enrollment Ahead of Schedule with Completion Expected Q2 2008 WESTMINSTER, Colo., Sept. 24 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced the completion of pre-planned interim analyses of patient response and safety data from the Company's pivotal ...
... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeut...
...faproxyn and focus on advancing the development of pdx (pralatrexate), its novel antifolate currently und...rmination in advancing the clinical development of pdx and RH1, and look forward to providing future upda...icer. "We expect to provide the next update on our pdx PROPEL study later this year following completion ...
PROPEL Enrollment Ahead of Schedule with Completion Expected Q2 2008 WESTMINSTER, Colo., Sept. 24 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced the completion of pre-planned interim analyses of patient response and safety data from the Company's pivotal ...
Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
WESTMINSTER, Colo., Aug. 15 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ) today announced the initiation of patient enrollment in a Phase 1, open-label, multi-center study of the Company's novel antifolate PDX (pralatrexate) with vitamin B12 and folic acid supplementation...Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission
WESTMINSTER, Colo., April 19, 2007 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. today announced that the Commission of the European Communities, with a favorable opinion of the Committee for Orphan Medicinal Products of the European Medicines Agency (EMEA), has granted orphan drug designatio...... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeut...
ApoCell's Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
...t. ApoCell has developed an analytical tool, the pdx Index(TM) (Pharmaco-Diagnostic Index), which indic...President and CEO comments, "We have developed the pdx Index(TM) methodology to give drug developers, cli...e same cancer drug therapy. By knowing a patient's pdx Index(TM) score ahead of time, the physician can p......faproxyn and focus on advancing the development of pdx (pralatrexate), its novel antifolate currently und...rmination in advancing the clinical development of pdx and RH1, and look forward to providing future upda...icer. "We expect to provide the next update on our pdx PROPEL study later this year following completion ...
PDX in Biological News
A molecular switch turns on the flame in 'nature's blowtorch'
...orientation around the peptide bond, and moves the P450 from the form in which substrate binds to the active form. After the reaction is finished, the pdx falls off, the P450 moves back to the unactivated state, and the oxidized products are free to leave. After another substrate molecule and oxygen m...PDX in Biological Technology
Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
MTD in NSCLC Identified; Phase 2 Study Planned WESTMINSTER, Colo., Oct. 25 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. (Nasdaq: ALTH ), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, ...... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemotherapeut...
Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference
... agreement reached with the U.S. Food and Drug Administration under its special protocol assessment, or SPA process. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of other lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemothe...Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
...ntly under evaluation in a pivotal Phase 2 trial in patients with relapsed or refractory peripheral T-cell lymphoma. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of other lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemothe...Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference
...ntly under evaluation in a pivotal Phase 2 trial in patients with relapsed or refractory peripheral T-cell lymphoma. The Company is also investigating pdx in patients with non-small cell lung cancer and a range of other lymphoma sub-types. The Company's other product candidate is RH1, a targeted chemothe...Other TagsChromatographyChromosomesChymeOther Contentsbunionburnsburnsburnsburnsburnsbunionsbursabursitiscalcificationcalcification
ChlorophyllChlorophytaChloroplastChloroplastsChordatesChordateChromatinChromatidChromatographyChromomereChromosomesChymeCiliophoraCilium
(Date:11/29/2009)...., Nov. 29 Acuo Technologies, deve...t software, data migration tools and services, tod...re that allows image sharing across the networks o...cuoShare solution is based on the versatile Acuo T... Acuo AcuoShare enables secure access from various...
(Date:11/29/2009)...aditional healthcare,s uncertain future and rising...tive care. Affordable Acupuncture Scottsdale answe...vember 29, 2009 -- Affordable Acupuncture, LLC ope...has been met with enthusiasm and gratitude. Its in...buted to two things, need and cost. "As far ...
(Date:11/28/2009)...ift spirits, recognize signs of depression , ...any seniors, the holiday season can trigger melanc... with health issues or worry about money problems,..., To help overcome the seasonal blues, the AGS Fou...dvice: , Get out and socialize or invite family ...
(Date:11/27/2009)...v. 27 The Gymboree Corpo...rt, CFO/COO, will present at the NASDAQ OMX 23rd I...r Hotel in London, England, on Wednesday, December...live broadcast of The Gymboree Corporation,s prese...mboree.com, click on "Our Company" at the bottom o...
(Date:11/27/2009)...-emission vehicles may reduce future disease burde...HealthDay News) -- Encouraging city dwellers to wa...uch greater public health benefits than increased ...ve found. , The study compared the projected he...nsport scenarios for London, England, and Delhi, I...
Breaking Medicine News(10 mins):Health News:Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:More Foot Power, Less Car Pollution Best for Health 2[0] Acuo Technologies Announces a New Offering That Enables Sharing of Imaging Studies Securely and Affordably[0] Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities[1] Seniors May Need Help Overcoming Holiday Blues[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] More Foot Power, Less Car Pollution Best for Health
(Date:11/25/2009)...ach, may be used to boost resistance to, or slow, ...l of Medicine researchers report in a study publis...nce . , Parkinson,s disease is caused by a degen...rain known as the substantia nigra, which is respo...n of dopamine in late-stage Parkinson,s causes sym...
(Date:11/25/2009)... the linchpin of the environment, where atmosphere...any students see soil as "just dirt" a place to g...rs are challenged with the task of helping student... of soil in the environment. , A collaborative ... at University of Nebraska-Lincoln, Oregon State U...
(Date:11/24/2009)...cribed by traditional healers in Brazil to treat a... to fever and flu. , Now for the first time, rese...scientifically prove the pain relieving properties... mint. , Testing this ancient South American herb...a was able to show that when prepared as a ,tea, ...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2AMA Manual of Style the Bible for Medical and Scientific Publishing Gains Online Presence 50347 1AMA Manual of Style the Bible for Medical and Scientific Publishing Gains Online Presence 50347 2AUDIO from Medialink and AARP 3A Helping Older Americans Buy Groceries in a Snap 50343 1Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 1Live Broadcast of Drug Rehab Graduation at Canadian Narconon 50339 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |